Skip to main content

Cuyahoga, Summit Counties Opioid Trial Set For Oct. 2020

Cuyahoga, Summit Counties Opioid Trial Set For Oct. 2020

Cuyahoga, Summit Counties Opioid Trial Set For Oct. 2020

Introduction

On Tuesday, U.S. District Judge Dan Polster in an order stated that he would preside over a trial starting Oct. 7, 2020, for claims made by Cuyahoga and Summit counties against pharmacy companies for fuelling the opioids epidemic.

According to the order, that involves trial against CVS, Walgreens, Rite Aid, Discount Drug Mart, and HBC, which is part of Giant Eagle, the jury selection for the trial will take place between Oct. 7 and Oct. 9, 2020. The Opening statements will commence the following Tuesday, Oct. 13.

The judge in the order noted that trying the case in Cleveland with the two counties will result in faster discovery as the counties produced documents to the defendants when preparing for last month’s canceled trial. The drug manufacturers had also produced documents to the counties in the lead up to the trial.

In a separate order, Judge Polster wrote that it would be best if lawsuits filed by Chicago, the Cherokee Nation, and the city and county of San Francisco were immediately sent back to the courts where they originated so federal judges in other states can oversee proceedings and preside over trials.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.